CVS to Cover Lilly’s GLP-1 Medications, Expanding Access
CVS Health will broaden coverage for Lilly’s GLP-1 medications, including the new pill Foundayo and Zepbound injectio...
Connect with industry professionals using effective methods. Discover ways to enhance your network and open new opportunities.
16,127 articlesCVS Health will broaden coverage for Lilly’s GLP-1 medications, including the new pill Foundayo and Zepbound injectio...
Microsoft and Apple are rolling out platform-native features at Build and WWDC that could squeeze rival apps. Investo...
Young men are flocking to prediction markets for quick payouts and heightened excitement, but analysts warn the bets ...
Meta unveils a bold workforce program that funds a 5-week training path and guarantees employment for data-center tec...
A wave of data center spending powered by AI is reshaping the investment landscape. This article explains which stock...
A bipartisan bill would establish a Federal Cryptocurrency Theft Task Force within the DOJ, aiming to coordinate pros...
Billionaire investor Bill Ackman points to SpaceX's durable cash-flow engines, highlighting a cornerstone of value as...
Ripple has won preliminary approval for a MiCA-based CASP license in Luxembourg, paving the way for regulated crypto ...
Executives from SpaceX and Charter are in early talks about a consumer mobile service that could route SpaceX phone t...
Open Standard announces Open USD, a new stablecoin backed by 140 plus firms including Stripe and Visa, set to launch ...
A California winery cofounder launches a program to cover living costs for families affected by cancer, challenging t...
Ford faces renewed scrutiny as recalls mount and U.S. sales soften, fueling a debate over whether ford should give ba...